- Report
- March 2026
- 209 Pages
Global
From €4415EUR$4,950USD£3,787GBP
- Report
- October 2025
- 96 Pages
Global
From €4014EUR$4,500USD£3,443GBP
- Report
- September 2025
- 140 Pages
Global
From €4326EUR$4,850USD£3,710GBP
- Report
- March 2026
- 286 Pages
United States
From €4326EUR$4,850USD£3,710GBP
- Report
- March 2026
- 107 Pages
Asia Pacific
From €3523EUR$3,950USD£3,022GBP
- Report
- March 2026
- 104 Pages
Europe
From €3523EUR$3,950USD£3,022GBP
- Report
- March 2026
- 80 Pages
Africa, Middle East
From €3077EUR$3,450USD£2,639GBP
- Report
- March 2026
- 88 Pages
North America
From €3077EUR$3,450USD£2,639GBP
- Report
- October 2025
- 90 Pages
Middle East
From €4014EUR$4,500USD£3,443GBP
- Report
- September 2026
Global
From €450EUR$540USD£399GBP
- Report
- March 2025
- 84 Pages
Global
From €400EUR$480USD£355GBP
- Report
- October 2021
- 433 Pages
Global
From €2250EUR$2,702USD£1,997GBP
- Report
- August 2023
- 250 Pages
Global
From €2221EUR$2,490USD£1,905GBP
- Report
- December 2024
- 120 Pages
Global
From €5307EUR$5,950USD£4,552GBP
- Report
- October 2024
- 100 Pages
Global
From €5307EUR$5,950USD£4,552GBP
- Report
- August 2025
- 189 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- August 2025
- 194 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- August 2025
- 183 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- August 2025
- 180 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- August 2025
- 186 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP

Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases.
In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more